Find information on thousands of medical conditions and prescription drugs.

Apresoline

Hydralazine hydrochloride (1 -hydrazinophthalazine monohydrochloride; Apresoline®) is a medication used to treat high blood pressure. A vasodilator, hydralazine works by relaxing blood vessels and increasing the supply of blood and oxygen to the heart while reducing its workload. It is commonly used in the condition of pregnancy called preeclampsia. more...

Home
Diseases
Medicines
A
8-Hour Bayer
Abacavir
Abamectin
Abarelix
Abciximab
Abelcet
Abilify
Abreva
Acamprosate
Acarbose
Accolate
Accoleit
Accupril
Accurbron
Accure
Accuretic
Accutane
Acebutolol
Aceclidine
Acepromazine
Acesulfame
Acetaminophen
Acetazolamide
Acetohexamide
Acetohexamide
Acetylcholine chloride
Acetylcysteine
Acetyldigitoxin
Aciclovir
Acihexal
Acilac
Aciphex
Acitretin
Actifed
Actigall
Actiq
Actisite
Actonel
Actos
Acular
Acyclovir
Adalat
Adapalene
Adderall
Adefovir
Adrafinil
Adriamycin
Adriamycin
Advicor
Advil
Aerobid
Aerolate
Afrinol
Aggrenox
Agomelatine
Agrylin
Airomir
Alanine
Alavert
Albendazole
Alcaine
Alclometasone
Aldomet
Aldosterone
Alesse
Aleve
Alfenta
Alfentanil
Alfuzosin
Alimta
Alkeran
Alkeran
Allegra
Allopurinol
Alora
Alosetron
Alpidem
Alprazolam
Altace
Alteplase
Alvircept sudotox
Amantadine
Amaryl
Ambien
Ambisome
Amfetamine
Amicar
Amifostine
Amikacin
Amiloride
Amineptine
Aminocaproic acid
Aminoglutethimide
Aminophenazone
Aminophylline
Amiodarone
Amisulpride
Amitraz
Amitriptyline
Amlodipine
Amobarbital
Amohexal
Amoxapine
Amoxicillin
Amoxil
Amphetamine
Amphotec
Amphotericin B
Ampicillin
Anafranil
Anagrelide
Anakinra
Anaprox
Anastrozole
Ancef
Android
Anexsia
Aniracetam
Antabuse
Antitussive
Antivert
Apidra
Apresoline
Aquaphyllin
Aquaphyllin
Aranesp
Aranesp
Arava
Arestin
Arestin
Argatroban
Argatroban
Argatroban
Argatroban
Arginine
Arginine
Aricept
Aricept
Arimidex
Arimidex
Aripiprazole
Aripiprazole
Arixtra
Arixtra
Artane
Artane
Artemether
Artemether
Artemisinin
Artemisinin
Artesunate
Artesunate
Arthrotec
Arthrotec
Asacol
Ascorbic acid
Asmalix
Aspartame
Aspartic acid
Aspirin
Astemizole
Atacand
Atarax
Atehexal
Atenolol
Ativan
Atorvastatin
Atosiban
Atovaquone
Atridox
Atropine
Atrovent
Augmentin
Aureomycin
Avandia
Avapro
Avinza
Avizafone
Avobenzone
Avodart
Axid
Axotal
Azacitidine
Azahexal
Azathioprine
Azelaic acid
Azimilide
Azithromycin
Azlocillin
Azmacort
Aztreonam
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Administration

Oral, in tablets and suspension, or intravenous. In most adults, oral doses range from 40 mg to 200 mg a day, divided in 2 to 4 doses, while intravenous doses range from 5 to 40 mg, repeated as necessary.

Patients given hydralazine over a period of six months or more may develop a lupus-like syndrome or other immune related diseases that generally are reversible with withdrawal. Hydralazine is differentially acetylated by fast and slow acetylator phenotypes thus incidence of lupus-like disease in slow acetylators.

Side effects

Common side effects include:

  • Diarrhoea
  • Rapid heartbeat
  • Headache
  • Loss of appetite
  • Nausea or vomiting
  • Pounding heartbeat
  • Drug-induced lupus

Read more at Wikipedia.org


[List your site here Free!]


Diagnosing pericarditis
From American Family Physician, 11/1/02 by Krishan K. Goyle

Pericarditis is inflammation of the pericardial sac surrounding the heart and the origins of the great vessels. (1) The condition is most often caused by a viral infection and generally resolves in a few weeks with no sequelae.

Severe pericardial syndromes are relatively uncommon, and their clinical features are largely determined by the amount and type of fluid produced by the inflammatory process. (1,2) The normal pericardial sac contains 15 to 20 mL (maximum: 50 mL) of serous fluid, which lubricates cardiac motion. (3) In pericarditis, the accumulation of serous fluid, inflammatory cells, and fibrin may compromise cardiac function.

Over time, pericarditis can result in chronic inflammation with thickening and, ultimately, calcification of the pericardium. This condition is known as "chronic constrictive pericarditis." Conversely, rapid accumulation of serous fluid can result in acute compression of the cardiac chambers, with dire hemodynamic consequences. (3,4) This condition, which is called "cardiac tamponade," may occur in up to 15 percent of patients with severe pericarditis. (2)

Pericarditis can mimic other conditions, especially myocardial infarction. Family physicians should be alert to the possibility of pericarditis in patients with chest pain, because misdiagnosis can have potentially fatal consequences. In particular, hemorrhage and fatal cardiac compression can occur if thrombolytic therapy is given to patients who have pericarditis.

Etiology

Although viral infection is the most common cause of pericarditis, (5) the condition has many possible causes (6,7) (Table 1), including bacterial infection, myocardial infarction, trauma, malignancy, uremia, hypothyroidism, collagen vascular disease, and the effects of certain drugs, notably hydralazine (Apresoline) and procainamide (Pronestyl). Purulent pericarditis as a result of bacterial infection (e.g., tuberculosis) is now rare, but human immunodeficiency virus infection has become an increasingly common cause of the condition. (8,9) Many infections that cause pericarditis, particularly fungal and nonbacterial infections, occur most often in immunocompromised patients.

Pericarditis may complicate myocardial infarction on the second to fourth day after the acute event as a reaction to underlying necrotic myocardium. The condition may also be a prominent feature of postmyocardial infarction syndrome (Dressler's syndrome), which develops weeks to months after acute infarction. In this situation, pericarditis occurs because of a late autoimmune reaction stimulated by the entry of necrotic myocardial tissue into the circulation, where it acts as an antigen.

Pericarditis is a feature of several autoimmune conditions, especially systemic lupus erythematosus. It is also associated with renal failure and hemodialysis. Furthermore, pericarditis can develop because of injury to the pericardium as a result of trauma, surgery, instrumentation, or radiation therapy.

Pathophysiology and Classification

Depending on the underlying cause, the acute inflammatory response in pericarditis may produce serous fluid, pus, or dense fibrinous material. Viral pericarditis usually results in small accumulations of serous fluid that resolve spontaneously or require minimal therapeutic intervention. Even large volumes of serous fluid (up to 250 mL) may not cause significant clinical signs or symptoms if accumulation is gradual. The effusion may only be apparent as an enlarged cardiac silhouette on the chest radiograph. (3)

Conversely, large acute accumulations of pericardial fluid may cause intrapericardial pressure to rise, thereby impeding filling of the right side of the heart through the superior vena cava and inferior vena cava. Acutely, this situation can result in cardiac tamponade. If the pericarditis process continues and the fluid organizes into a thickened (even calcified) coating, the resultant constrictive pericarditis may mimic restrictive cardiomyopathy. (4,10,11) Thus, pericarditis may be classified as acute, subacute, or chronic, depending on the underlying pathophysiologic process (Table 2).

Hemodynamic Considerations

Changes in the jugular veins and the relationship of those changes to respiration can be extremely useful in differentiating pericarditis from other causes of chest pain and related symptoms. These changes also can be crucial in recognizing cardiac tamponade and constrictive pericarditis. (1-3,11)

The normal jugular vein examination shows two positive waves (the a wave during atrial systole and the v wave during ventricular systole) and two negative waves (the x descent during atrial diastole and the y descent during ventricular systole). During inspiration, lung expansion causes negative intrathoracic pressure that is transmitted to the pericardium and cardiac chambers, leading to dilation of the chambers. As a result, the right chambers of the heart fill with blood from the superior vena cava and the inferior vena cava, and the left chambers fill because of forward flow in the pulmonary veins.

Even with a moderately large effusion, mild acute pericarditis usually has no hemodynamic impact on the heart. Hence, jugular venous profiles are generally normal.

Conversely, cardiac tamponade and constrictive pericarditis lead to important and distinctive hemodynamic changes. Because the heart is constricted by fluid or a rigid fibrinous or calcified pericardium, negative intrathoracic pressure during inspiration is not transmitted to the pericardial sac. Consequently, intrapericardial and intracardiac pressures remain elevated, and intrapericardial pressure equals or exceeds right atrial pressure.

In cardiac tamponade, this situation results in early right ventricular diastolic collapse and late diastolic right atrial collapse, because pressures are lowest in diastole. The y descent is blunted because the right ventricle cannot expand, but the x descent remains normal. In cardiac tamponade, some blood (though less than normal) still flows toward the right side of the heart during inspiration. Because the cardiac chambers are inhibited from dilating, the inflow causes the intraventricular septum to shift to the left, which further decreases left ventricular capacity.

The hemodynamic changes can cause systolic blood pressure to fall by 10 mm Hg or more during inspiration. This situation, termed "pulsus paradoxus," is the classic hallmark of cardiac tamponade. Pulsus paradoxus is detectable in 70 to 80 percent of patients with cardiac tamponade and in about one third of patients with pericarditis. (2)

In constrictive pericarditis, no forward flow occurs from the superior vena cava and the inferior vena cava during inspiration. This results in Kussmaul's sign, which is a paradoxic inspiratory swelling of the neck veins. Because blood flow to the right side of the heart does not increase, no septal shift occurs, and pulsus paradoxus is not common in constrictive pericarditis.

Clinical Features

Patients usually recall a nonspecific prodrome of malaise, fever, and chest pain, especially in viral or idiopathic pericarditis. The chest pain is typically pleuritic and radiates to the left shoulder and, characteristically, the left trapezius musculature. The pain is exacerbated by inspiration or recumbency and relieved to some extent by leaning forward. Patients may have additional symptoms, depending on the etiology of the pericarditis and the presence of complications.

Clinical signs may be subtle. A pericardial friction rub may or may not be present. Large effusions are unlikely to produce a pericardial rub. With large, slowly accumulating effusions, there may be dullness to percussion in the scapular region because of compression of the left lung (Ewart's sign).

As previously noted, acute, rapid accumulation of fluid in the pericardium causes signs of acute hemodynamic compromise in cardiac tamponade. Patients with this condition develop tachycardia, hypotension, pulsus paradoxus, and distended neck veins. Although these patients appear to be in acute distress (similar to cardiac failure and pulmonary edema), their lungs are clear on auscultation.

In chronic constrictive pericarditis, (4) the neck veins are markedly distended, but patients do not appear distressed and show no evidence of pulsus paradoxus. During inspiration, the neck veins become distended (normally, they collapse). The jugular venous pulse shows a sharp y descent because of rapid right ventricular filling in early diastole. A sharp heart sound called a "pericardial knock" is heard in early diastole. Unless other problems are present, the lungs are usually clear on auscultation. Because of congestion of the inferior vena cava, the liver is enlarged, and ascites and peripheral leg edema are evident. Clinical features may mimic those of restrictive cardiomyopathy.

Diagnosis

The diagnosis of pericarditis and its complications requires a high index of suspicion. Clinical features and the probability of a cause of pericarditis (Table 1) may assist in recognition. Potential confirmatory studies include the electrocardiogram (ECG), the chest radiograph, Doppler studies, and selected laboratory tests. A suggested approach to the diagnosis of pericarditis is provided in Figure 1. (2)

ELECTROCARDIOGRAPHY

In acute pericarditis, the ECG typically shows ST-segment elevation in all leads, with an upward concavity of the elevation (so-called "smiling face"). The PR segment is depressed. Unlike myocardial infarction, there is no reciprocal change, and T waves are not inverted. (12-15)

In this situation, the differential diagnosis includes acute myocardial infarction and normal-variant repolarization abnormality. It is particularly important to distinguish pericarditis from acute myocardial infarction, because thrombolytic therapy could have disastrous effects in patients with pericarditis. Characteristic features of acute pericarditis, acute myocardial infarction, and early repolarization are summarized in Table 3. Examples illustrating the ECG differentiation of the three conditions are provided in Figure 2. (16)

[FIGURE 2 OMITTED]

In cardiac tamponade, the ECG shows electrical alternans as the heart "floats" in relation to the recording leads. Chronic constrictive pericarditis presents with low voltage of the QRS complex and diffuse flattening or inversion of the T waves. Atrial fibrillation occurs in one third of patients with pericardial disease.

CHEST RADIOGRAPHY

If more than 250 mL of fluid has accumulated, the cardiac silhouette is usually enlarged on the chest radiograph. Smaller accumulations may appear normal. In constrictive pericarditis, calcification may be seen around the heart.

DOPPLER STUDIES

The diagnostic test of choice for large effusions, cardiac tamponade, and constrictive pericarditis is two-dimensional Doppler echocardiography. This imaging modality can demonstrate moderate or large effusions. In cardiac tamponade, Doppler examination may show the characteristic swinging motion of the heart that gives rise to electrical alternans.

Doppler examination can also show the reversal of inflow velocities in the tricuspid and mitral valves during inspiration and expiration. Divergence of right and left ventricular systolic pressures is demonstrated in cardiac tamponade and constrictive pericarditis. Doppler studies differentiate pericarditis from restrictive cardiomyopathy. (3,10,17)

LABORATORY TESTS

Laboratory studies are useful for excluding other possible causes of symptoms and clarifying the underlying cause of pericarditis. Testing is individualized but frequently includes a complete blood cell count (CBC), an erythrocyte sedimentation rate (ESR), cardiac enzyme levels, and serum chemistries. Nonspecific elevations in the CBC and ESR are common in patients with pericarditis.

Treatment

Most patients with idiopathic pericarditis can be managed conservatively with a nonsteroidal anti-inflammatory drug (NSAID) such as indomethacin (Indocin), ibuprofen (e.g., Advil, Motrin), or acetylsalicylic acid (aspirin). These agents are believed to be equally effective, and the literature does not indicate an NSAID of choice for pericarditis.

Patients who do not respond to an NSAID may need a short course of a corticosteroid, usually prednisone in a dosage of 5 to 10 mg per day for one to two weeks. Rarely, patients do not respond to this therapy or show evidence of recurrent pericarditis. These patients require a prolonged corticosteroid course (i.e., several months).

Colchicine may be a useful alternative in patients who cannot take NSAIDs and corticosteroids or have major side effects with these agents. (18)

Indications for hospitalization include elevated neck veins, tachycardia, hypotension, poor pain control, and elevated cardiac enzyme levels. Patients also should be hospitalized if they have pulsus paradoxus, electrical alternans on the ECG, or a large pericardial effusion. Patients with chronic, large pericardial effusion may be asymptomatic but can develop cardiac tamponade precipitously. Thus, pericardiocentesis is indicated, and pericardectomy should be performed if the effusion recurs after percutaneous drainage. (11)

Pericardiocentesis is best performed in a controlled setting by an experienced physician. The patient is placed in a semirecumbent position (approximately 45- to 60-degree elevation). The pericardiocentesis needle is introduced into the subxiphoid angle and aimed toward the left shoulder. Distally, the needle is attached to an ECG monitor. Detection of ST-segment elevation during the procedure suggests injury to the myocardium. In cardiac tamponade, emergency pericardiocentesis can be lifesaving, because drainage of even a small amount of fluid changes the volume-pressure relationship significantly.

For continuous drainage, a catheter may be left in the pericardial sac, or a pericardial window may be created surgically. Pericardiocentesis may result in recurrent effusive-adhesive pericarditis, especially in uremic, malignant, or bacterial pericardial effusions. These conditions frequently require the creation of a pericardial window.

Pericardiectomy is the treatment of choice for chronic constrictive pericarditis. In asymptomatic patients and patients who are not considered surgical candidates, cautious diuretic therapy may be considered. Because atrial dysrhythmias (particularly atrial fibrillation) are common in patients with pericarditis, ventricular rate control should be initiated using a calcium channel blocker (verapamil [Calan, Isoptin] or diltiazem [Cardizem], but not nifedipine [Procardia]) or a beta blocker.

In certain situations, patients with cardiac tamponade or hemopericardium must go directly to surgery. Needle pericardiocentesis will exsanguinate patients with proximal aortic dissection or cardiac rupture. (3)

The authors indicate that they do not have any conflicts of interest. Sources of funding: none reported.

REFERENCES

(1.) Braunwald E. Heart disease: a textbook of cardiovascular medicine. 5th ed. Philadelphia: Saunders, 1997:1478-523.

(2.) MKSAP 12: medical knowledge self-assessment program. Philadelphia: American College of Physicians-American Society of Internal Medicine, 2001:50-4.

(3.) Murphy JG. Mayo Clinic cardiology review. 2d ed. Philadelphia: Lippincott Williams & Wilkins, 2000: 509-32.

(4.) Myers RB, Spodick DH. Constrictive pericarditis: clinical and pathophysiologic characteristics. Am Heart J 1999;138(2 pt 1):219-32.

(5.) Goland S, Caspi A, Malnick SD. Idiopathic chronic pericardial effusion [Letter]. N Engl J Med 2000; 342:1449.

(6.) Narita H, Ohte N, Yoneyama A, Hashimoto T, Akita S, Sakuma N. Takayasu's arteritis accompanied with massive pericardial effusion--a case report. Angiology 1999;50:421-5.

(7.) Sentongo TA, Piccoli DA. Recurrent pericarditis due to mesalamine hypersensitivity: a pediatric case report and review of the literature. J Pediatr Gastroenterol Nutr 1998;27:344-7.

(8.) Chen Y, Brennessel D, Walters J, Johnson M, Rosner F, Raza M. Human immunodeficiency virus- associated pericardial effusion: report of 40 cases and review of the literature. Am Heart J 1999;137: 516-21.

(9.) Silva-Cardoso J, Moura B, Martins L, Mota-Miranda A, Rocha-Goncalves F, Lecour H. Pericardial involvement in human immunodeficiency virus infection. Chest 1999;115:418-22.

(10.) Oh JK, Hatle LK, Seward JB, Danielson GK, Schaff HV, Reeder GS, et al. Diagnostic role of Doppler echocardiography in constrictive pericarditis. J Am Coll Cardiol 1994;23:154-62.

(11.) Sagrista-Sauleda J, Angel J, Permanyer-Miralda G, Soler-Soler J. Long-term follow-up of idiopathic chronic pericardial effusion. N Engl J Med 1999; 341:2054-9.

(12.) Chan TC, Brady WJ, Pollack M. Electrocardiographic manifestations: acute myopericarditis. J Emerg Med 1999;17: 865-72.

(13.) Jain A. "Tombstone" anterior ST-segment elevations secondary to acute pericarditis: the role of two-dimensional echocardiogram. Clin Cardiol 1997;20:404-6.

(14.) Marinella MA. Electrocardiographic manifestations and differential diagnosis of acute pericarditis. Am Fam Physician 1998;57:699-704.

(15.) Baljepally R, Spodick DH. PR-segment deviation as the initial electrocardiographic response in acute pericarditis. Am J Cardiol 1998;81:1505-6.

(16.) Debehnke DJ. Cardiac-related acute infectious disease. In: Gibler WB, Aufderheide TP, eds. Emergency cardiac care. St. Louis: Mosby, 1994:463-88.

(17.) Eisenberg MJ, Oken K, Guerrero S, Saniei MA, Schiller NB. Prognostic value of echocardiography in hospitalized patients with pericardial effusion. Am J Cardiol 1992;70:934-9.

(18.) Adler Y, Guindo J, Finkelstein Y, Khouri A, Assali A, Bayes-Genis A, et al. Colchicine for large pericardial effusion. Clin Cardiol 1998;21:143-4.

KRISHAN K. GOYLE, M.D., has a private cardiology practice and is also associate professor at the University of Kansas School of Medicine, Wichita. Dr. Goyle received his medical degree from All India Institute of Medical Sciences, New Delhi. He completed an internal medicine residency at the University of Rochester (N.Y.) and a cardiology fellowship at the Cleveland Clinic Foundation.

ANNE D. WALLING, M.D., is associate dean for faculty development and professor in the Department of Family and Community Medicine at the University of Kansas School of Medicine, Wichita. Dr. Walling received her medical degree from the University of St. Andrews, Scotland, and completed postdoctoral training in community medicine and public health in London. She is a former secretary-treasurer of the Society of Teachers of Family Medicine and presently serves as associate editor of American Family Physician.

Address correspondence to Krishan K. Goyle, M.D., University of Kansas School of Medicine, 1010 N. Kansas, Suite 3207, Wichita, KS 67214-3199 (e-mail: kgoyle@yahoo.com). Reprints are not available from the authors.

COPYRIGHT 2002 American Academy of Family Physicians
COPYRIGHT 2002 Gale Group

Return to Apresoline
Home Contact Resources Exchange Links ebay